S

Sporos Bioventures

13 employees

Sporos Bioventures is a biotechnology firm that aims to catalyze the rapid and accurate development of cancer and immune disease treatments.

Investor insights

Sectors invested in

Biotechnology4
Health Care3
Pharmaceutical2
Service Industry1
Therapeutics1
Biopharma1
Fibrosis1
Cancer1
STAT31
Inflammation1
Small Molecules1

Funding rounds participated in

$16M sweet spot round size

Most of their 4 investments are in rounds between $14M and $16M

Investor type

Venture Capital

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Therapeutics

Date founded

2020

Investments made

T

Tvardi Therapeutics raised $72M on June 15, 2021

Investors: Slate Path Capital LP and Sporos Bioventures

S

Stellanova Therapeutics raised $16M on June 3, 2021

Investors: Sporos Bioventures

-

- raised $15M on May 25, 2021

Investors: Sporos Bioventures

N

Nirogy Therapeutics raised $17M on January 26, 2021

Investors: - and Sporos Bioventures

FAQ